Literature DB >> 21271502

[Frequency and influencing factors of ketoacidosis at diabetes onset in children and adolescents--a long-term study between 1995 and 2009].

B Karges1, A Neu, S E Hofer, J Rosenbauer, W Kiess, H Rütschle, A Dost, H Kentrup, R W Holl.   

Abstract

BACKGROUND: Diabetic ketoacidosis (DKA) is a frequent acute complication at onset of type 1 diabetes. It is assumed that increased public awareness about diabetes symptoms may reduce DKA rate at diabetes onset. To investigate the time-dependent trend in DKA prevalence we analysed the frequency and determinants of DKA at disease onset over 15 years in pediatric patients. PATIENTS AND METHODS: The prevalence of DKA at disease onset was analysed in individuals aged ≤18 years treated for the first time from 1995-2009 within 7 days after diagnosis in pediatric centers. Simple and multiple logistic regression analysis was performed to investigate influencing factors on DKA prevalence. Change of the probability of ketoacidosis over years were modelled in the logistic regression as linear trend.
RESULTS: 16 562 individuals from 170 institutions were studied with a mean age of 9.2 ± 4.2 years. DKA (pH <7.3) was present in 20.8% of patients without a significant trend between 1995 and 2009 (p=0.222). DKA prevalence was higher in children ≤5 years (26.3%) and in the age group 10-15 years (21.7%) than in individuals aged 5-10 years (16.4%) and 15-18 years (16.9%, p<0.001). Girls had DKA more often than boys (21.2% vs. 19.3%, p=0.002). DKA frequency was increased in individuals with migration background (26.5% vs. 19.2%, p<0.001).
CONCLUSIONS: DKA prevalence at diabetes onset was constant at about 21% during the last 15 years. Very young children, pubertal adolescents, girls and individuals with migration background are at higher risk for DKA at diagnosis. To prevent DKA earlier diagnosis of type 1 diabetes is warranted especially in these patient groups. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21271502     DOI: 10.1055/s-0030-1269884

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  6 in total

1.  Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.

Authors:  S Fredheim; J Johannesen; A Johansen; L Lyngsøe; H Rida; M L M Andersen; M H Lauridsen; B Hertz; N H Birkebæk; B Olsen; H B Mortensen; J Svensson
Journal:  Diabetologia       Date:  2013-02-07       Impact factor: 10.122

2.  Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children.

Authors:  Arleta Rewers
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

3.  Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.

Authors:  Katja Konrad; Angelika Thon; Maria Fritsch; Elke Fröhlich-Reiterer; Eggert Lilienthal; Stefan A Wudy; Reinhard W Holl
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

4.  [Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic].

Authors:  Kirsten Mönkemöller; Clemens Kamrath; Johanna Hammersen; Torben Biester; Katharina Warncke; Angeliki Pappa; Katharina Fink; Klemens Raile; Tilman R Rohrer; Reinhard W Holl
Journal:  Monatsschr Kinderheilkd       Date:  2021-01-08       Impact factor: 0.323

5.  Frequency and Risk Factors of Diabetic Ketoacidosis in a Specialized Children's Hospital, Riyadh: A Cross-sectional Study.

Authors:  Amir Babiker; Ghadeer L Aljahdali; Mohammed K Alsaeed; Abdulrahman F Almunif; Mohamud S Mohamud; Angham Al Mutair; Fahad Al Juraibah; Ibrahim Al Alwan
Journal:  Oman Med J       Date:  2022-01-31

6.  Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes.

Authors:  Christina Bächle; Andrea Icks; Klaus Straßburger; Marion Flechtner-Mors; Andreas Hungele; Peter Beyer; Kerstin Placzek; Ulrich Hermann; Andrea Schumacher; Markus Freff; Anna Stahl-Pehe; Reinhard W Holl; Joachim Rosenbauer
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.